Dermatofibrosarcoma protuberans with fibrosarcomatous differentiation (DFSP-FS) is a rare variant of DFSP with a more aggressive clinical course, characterized by higher rates of local recurrence, metastasis, and death.
Methods:
We conducted a clinicopathologic review of all DFSP-FS cases that occurred in Alberta, Canada, from 1997 to 2007.
Results:
Of the 75 DFSP cases reviewed, 4 demonstrated fibrosarcomatous differentiation. Three patients were female and one was male, and the age range was 25 to 76 years. Three tumors invaded to skeletal muscle, whereas one invaded to subcutaneous tissue only. Although perineural invasion was noted in all four cases, none exhibited lymphovascular space invasion. One local recurrence developed, and two of four tumors metastasized. Metastasis was associated with tumor size, tumor necrosis, grenz zone involvement, ulceration, thickness, and tumor grade. One patient died within 5 years of diagnosis.
Conclusion:
DFSP-FS represents a more aggressive subtype of DFSP. Several features of DFSP-FS may impart a higher risk of metastasis.
Get full access to this article
View all access options for this article.
References
1.
KuzelPMetelitsaAIDoverDC. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007. Dermatol Surg2012;38:1461–8, doi:10.1111/j.1524-4725.2012.02482.x.
2.
BoguckiBNeuhausIHurstEA. Dermatofibrosarcoma protuberans: a review of the literature. Dermatol Surg2012;38:537–51, doi:10.1111/j.1524-4725.2011.02292.x.
3.
StacchiottiSPedeutourFNegriT. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib. Int J Cancer2011;129:1761–72, doi:10.1002/ijc.25826.
4.
BeckerJCLiegl-AtzwangerBUgurelS. Malignant fibrous, fibrohistiocytic, and histiocytic tumors of the dermis. In: GoldsmithLKatzSGilchrestB editors. Fitzpatrick’s dermatology in general medicine. 8th ed.New York: McGraw-Hill; 2012. p. 1445–55.
5.
LlombartBMonteagudoCSanmartinO. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors. J Am Acad Dermatol2011;65:564–75, doi:10.1016/j.jaad.2010.06.020.
HongYJChoiYWMyungKB. A case of myxoid dermatofibrosarcoma protuberans. Ann Dermatol2011;23:379–81, doi:10.5021/ad.2011.23.3.379.
8.
Sabater-MarcoVPerez-VallesABerzal-CantalejoF. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int J Dermatol2006;45:59–62, doi:10.1111/j.1365-4632.2004.02340.x.
9.
BanerjeeSSHarrisMEydenBP. Granular cell variant of dermatofibrosarcoma protuberans. Histopathology1990;17:375–8, doi:10.1111/j.1365-2559.1990.tb00745.x.
10.
BakryOAttiaA. Atrophic dermatofibrosarcoma protuberans. J Dermatol Case Rep2012;1:14–17.
11.
Warbrick-SmithJHollowoodKBirchJ. Dermatofibrosarcoma protuberans recurring as a hybrid dermatofibrosarcoma/giant cell fibroblastoma in an adult: a case report. J Plast Reconstr Aesthet Surg2010;63:785–7, doi:10.1016/j.bjps.2010.06.026.
12.
PennerDW. Metastasizing dermatofibrosarcoma protuberans: a case report. Cancer1951;4:1083–6, doi:10.1002/1097-0142(195109)4:5<1083::AID-CNCR2820040526>3.0.CO;2-#.
13.
VothHLandsbergJHinzT. Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol2011;25:1385–91, doi:10.1111/j.1468-3083.2011.04141.x.
14.
MentzelTBehamAKatenkampD. Fibrosarcomatous (“high-grade”) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol1998;22:576–87, doi:10.1097/00000478-199805000-00009.
15.
BowneWBAntonescuCRLeungDHY. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer2000;88:2711–20, doi:10.1002/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M.
16.
ErdemOWyattAJLinE. Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables. Am J Dermatopathol2012;34:24–34, doi:10.1097/DAD.0b013e3182120671.
17.
AbbottJJOliveiraAMNascimentoAG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol2006;30:436–43, doi:10.1097/00000478-200604000-00002.
18.
LemmDMuggeLOMentzelT. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol2009;135:653–65, doi:10.1007/s00432-009-0550-3.
19.
BachmannIMLadsteinRGStraumeO. Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer2008;8:362
doi:10.1186/1471-2407-8-362.
20.
ConnellyJHEvansHL. Dermatofibrosarcoma protuberans: a clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol1992;16:921–5, doi:10.1097/00000478-199210000-00001.
21.
SzollosiZNemesZ. Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight cases. J Clin Pathol2005;58:751–6, doi:10.1136/jcp.2004.019349.
22.
DingJHashimotoHEnjojiM. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinicopathologic study of nine cases and a comparison with allied tumors. Cancer1989;64:721–9, doi:10.1002/1097-0142(19890801)64:3<721::AID-CNCR2820640326>3.0.CO;2-Q.
23.
AngouridakisNKafasPJerjesW. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Head Neck Oncol2011;3:5. doi:10.1186/1758-3284-3-5.
24.
Sanz-TrellesAAyala-CarboneroARodrigo-FernandezI. Leiomyomatous nodules and bundles of vascular origin in the fibrosarcomatous variant of dermatofibrosarcoma protuberans. J Cutan Pathol1998;25:44–9, doi:10.1111/j.1600-0560.1998.tb01688.x.
